First Time Loading...

Chongqing Zhifei Biological Products Co Ltd
SZSE:300122

Watchlist Manager
Chongqing Zhifei Biological Products Co Ltd Logo
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Watchlist
Price: 35.1 CNY -1.68% Market Closed
Updated: May 4, 2024

Chongqing Zhifei Biological Products Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chongqing Zhifei Biological Products Co Ltd
Revenue Peer Comparison

Comparables:
6160
1801
603392
S
002252
300896

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Revenue
¥49.7B
CAGR 3-Years
53%
CAGR 5-Years
65%
CAGR 10-Years
50%
Beigene Ltd
HKEX:6160
Revenue
¥9.6B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Revenue
¥6.2B
CAGR 3-Years
17%
CAGR 5-Years
266%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Revenue
¥5.5B
CAGR 3-Years
33%
CAGR 5-Years
41%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Revenue
¥7.6B
CAGR 3-Years
41%
CAGR 5-Years
32%
CAGR 10-Years
27%
Imeik Technology Development Co Ltd
SZSE:300896
Revenue
¥1.9B
CAGR 3-Years
51%
CAGR 5-Years
54%
CAGR 10-Years
N/A

See Also

What is Chongqing Zhifei Biological Products Co Ltd's Revenue?
Revenue
49.7B CNY

Based on the financial report for Sep 30, 2023, Chongqing Zhifei Biological Products Co Ltd's Revenue amounts to 49.7B CNY.

What is Chongqing Zhifei Biological Products Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
50%

Over the last year, the Revenue growth was 36%. The average annual Revenue growth rates for Chongqing Zhifei Biological Products Co Ltd have been 53% over the past three years , 65% over the past five years , and 50% over the past ten years .